Cargando…
Emerging clinical applications of selected biomarkers in melanoma
Melanoma is a lethal skin disease with a mostly predictable clinical course according to a known constellation of clinical and pathologic features. The distinction of melanoma from benign melanocytic nevus is typically unequivocol; however, there is a subset of tumors known for its diagnostic challe...
Autores principales: | Tetzlaff, Michael T, Torres-Cabala, Carlos A, Pattanaprichakul, Penvadee, Rapini, Ronald P, Prieto, Victor G, Curry, Jonathan L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4321413/ https://www.ncbi.nlm.nih.gov/pubmed/25674009 http://dx.doi.org/10.2147/CCID.S49578 |
Ejemplares similares
-
Impact of the 2009 (7th Edition) AJCC Melanoma Staging System in the Classification of Thin Cutaneous Melanomas
por: Chu, Vicki H., et al.
Publicado: (2013) -
Reticulate hyperpigmentation in systemic sclerosis: a case report and review of the literature
por: Chuamanochan, Mati, et al.
Publicado: (2015) -
Aberrant DNA Methylation Predicts Melanoma-Specific Survival in Patients with Acral Melanoma
por: Pradhan, Dinesh, et al.
Publicado: (2019) -
Granulomatous/sarcoid-like lesions associated with checkpoint inhibitors: a marker of therapy response in a subset of melanoma patients
por: Tetzlaff, Michael T., et al.
Publicado: (2018) -
Immunohistochemical and Molecular Features of Melanomas Exhibiting Intratumor and Intertumor Histomorphologic Heterogeneity
por: Mejbel, Haider A., et al.
Publicado: (2019)